Cytosolic phosphorylated EGFR is predictive of recurrence in early stage penile cancer patients: A retropective study

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Di Lorenzo, Giuseppe ^a   Perdonà, Sisto ^b   Buonerba, Carlo ^a   Sonpavde, Guru ^c   Gigantino, Vincenzo ^b   Pannone, Giuseppe ^d   Quarto, Giuseppe ^b   Ferro, Matteo ^e   Gaudioso, Gabriella ^b   Terracciano, Daniela ^a   Di Trolio, Rossella ^b   Rescigno, Pasquale ^a   Botti, Gerardo ^b   De Placido, Sabino ^a   Facchini, Gaetano ^b   Ascierto, Paolo A ^b   Franco, Renato ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF FOGGIA   (Italy)

^e EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Epidermal growth factor receptor (EGFR) expression; Immunohistochemistry; Penile cancer; Phospo EGFR; Tissue micro array (TMA)

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EGFR PROTEIN, HUMAN;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; CANCER INFILTRATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER TISSUE; CELL NUCLEUS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORPUS CAVERNOSUM; CYTOSOL; EARLY CANCER; FLUORESCENCE IN SITU HYBRIDIZATION; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PENIS CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECURRENCE RISK; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE; SURVIVAL TIME; TIME OF RECURRENCE; TIME TO FOLLOW UP; WART VIRUS; CANCER STAGING; METABOLISM; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PENILE NEOPLASMS; PHOSPHORYLATION; STATISTICAL MODEL; SURVIVAL;

AGED; CYTOSOL; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PENILE NEOPLASMS; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84879824803     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-161     Document Type: Article

References (20)

1. Sonpavde G, Pagliaro LC, Buonerba C, Dorff TB, Lee RJ, Di Lorenzo G. Penile cancer: current therapy and future directions. Ann Oncol 2013, 24(5):1179-1189. 10.1093/annonc/mds635, 23293117.
2. Verhoeven RH, Janssen-Heijnen ML, Saum KU, Zanetti R, Caldarella A, et al. Population-based survival of penile cancer patients in Europe and the United States of America: no improvement since 1990. Eur J Cancer 2013, 49(6):1414-21. 10.1016/j.ejca.2012.10.029, 23231984.
3. Di Lorenzo G, Buonerba C, Federico P, Perdonà S, Aieta M, et al. Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis. BJU Int 2012, 110(11):E661-6.
4. Pizzocaro G, Algaba F, Horenblas S, Solsona E, Tana S, et al. EAU penile cancer guidelines 2009. Eur Urol 2010, 57(6):1002-12. 10.1016/j.eururo.2010.01.039, 20163910.
5. Kattan MW, Ficarra V, Artibani W, Cunico SC, et al. Nomogram predictive of cancer specific survival in patients undergoing partial or total amputation for squamous cell carcinoma of the penis. J Urol 2006, 175(6):2103-8. 10.1016/S0022-5347(06)00313-2, 16697813.
6. Lont AP, Kroon BK, Horenblas S, Gallee MP, Berkhof J, et al. Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer 2006, 119(5):1078-81. 10.1002/ijc.21961, 16570278.
7. Gunia S, Jain A, Koch S, Denzinger S, Götz S, Niessl N, May M. Periostin expression correlates with pT-stage, grading and tumour size, and independently predicts cancer-specific survival in surgically treated penile squamous cell carcinomas. J Clin Pathol 2013, Epub ahead of print.
8. Gunia S, Kakies C, Erbersdobler A, Hakenberg OW, Koch S, et al. Expression of p53, p21 and cyclin D1 in penile cancer: p53 predicts poor prognosis. J Clin Pathol 2012, 65(3):232-6. 10.1136/jclinpath-2011-200429, 22135025.
9. Kayes OJ, Loddo M, Patel N, Patel P, Minhas S, et al. DNA replication licensing factors and aneuploidy are linked to tumor cell cycle state and clinical outcome in penile carcinoma. Clin Cancer Res 2009, 15(23):7335-44. 10.1158/1078-0432.CCR-09-0882, 2788529, 19920109.
10. Stankiewicz E, Prowse DM, Ng M. Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomas. PLoS One 2011, 6(3):e17517. 10.1371/journal.pone.0017517, 3047574, 21407808.
11. Lavens N, Gupta R, Wood LA. EGFR overexpression in squamous cell carcinoma of the penis. Curr Oncol 2010, 17(1):4-6. 2993439, 21151400.
12. Kanematsu T, Yano S, Uehara H, Bando Y, Sone S. Phosphorylation, but not overexpression, of epidermal growth factor receptor is associated with poor prognosis of non-small cell lung cancer patients. Oncol Res 2003, 13(5):289-98.
13. Magkou C, Nakopoulou L, Zoubouli C, Karali K, Theohari I, et al. Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas. Breast Cancer Res 2008, 10(3):R49. 10.1186/bcr2103, 2481499, 18522728.
14. Aquino G, Pannone G, Santoro A, Liguori G, Franco R, et al. pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma: a tissue-microarray study with clinic-pathological correlations. Cancer Biol Ther 2012, 13(11):967-77. 10.4161/cbt.20991, 22825335.
15. Sobin LH, Wittekind C. TNM Classification of Malignant Tumours 2002, : Wiley.
16. Broders AC. SQUAMOUS-CELL EPITHELIOMA OF THE SKIN: A STUDY OF 256 CASES. Ann Surg 1921, 73(2):141-60. 10.1097/00000658-192102000-00001, 1410603, 17864409.
17. Backes DM, Kurman RJ, Pimenta JM, Smith JS. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control 2009, 20(4):449-57. 10.1007/s10552-008-9276-9, 19082746.
18. Kong CS, Narasimhan B, Cao H, Kwok S, Erickson JP, et al. The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 2009, 74(2):553-61. 10.1016/j.ijrobp.2009.02.015, 2768774, 19427557.
19. Necchi A, Nicolai N, Colecchia M, Catanzaro M, Torelli T, et al. Proof of activity of anti-epidermal growth factor receptor-targeted therapy for relapsed squamous cell carcinoma of the penis. J Clin Oncol 2011, 29:e650-2. 10.1200/JCO.2011.34.8367, 21632506.
20. Di Lorenzo G, Buonerba C, Gaudioso G, et al. EGFR mutational status in penile cancer. Expert Opin Ther Targets 2013, 17:501-5. 10.1517/14728222.2013.783571, 23517177.